本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Mereo Biopharma Group Plc

2.40
+0.06502.79%
成交量:96.68万
成交额:226.22万
市值:3.81亿
市盈率:-8.19
高:2.47
开:2.47
低:2.28
收:2.33
数据加载中...
2020/06/12

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/06/05

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/03/27

非美公司披露报告

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/18

SEC问询函

CORRESP [Cover] - Correspondence
2020/03/12

[修订]招股说明书

[Amend] Registration statement for certain foreign private issuers
2020/03/09

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/03/06

SEC问询函

CORRESP [Cover] - Correspondence
2020/03/06

[修订]招股说明书

[Amend] Registration statement for certain foreign private issuers
2020/03/02

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/28

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/21

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/19

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/18

员工持股计划

Securities to be offered to employees in employee benefit plans
2020/02/18

招股说明书

Registration statement for certain foreign private issuers
2020/02/18

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/12

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/10

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/14

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/13

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/22

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]